Identification of the 23 kDa subunit of tau protein kinase II as a putative activator of cdk5 in bovine brain  by Ishiguro, Koichi et al.
FEBS Letters 342 (1994) 203-208 
FEBS 13868 
Identification of the 23 kDa subunit of tau protein kinase II as a putative 
activator of cdk5 in bovine brain 
Koichi Ishiguro”p*, Shunsuke Kobayashib, Akira Omoria, Masako Takamatsu”, Sayuri Yonekuraa, 
Kaijiro Anzaib, Kazutomo Imahoria, Tsuneko Uchida” 
‘~it~bishi Kazei Institute of Life Sciences, 1I ~i~~iooyu, ~a~hi&-shi, Tokyo 194, Japan 
%‘ollege of Pharmacy, Nihon University, Narashinodai, Funabashi-shi, Chiba 274, Japan 
Received 3 February 1994; revised version received 1 March 1994 
Tau protein kinase II (TPKII) was reported previously to be composed of a neuron-rich cdc2-related kinase (PSSALREfcdkS) and 23 kDa subunit. 
Here we show that the 23 kDa subunit is a putative activator for the kinase activity. Amino acid sequence analysis revealed that the protein was 
novel and included a partial similarity of amino acids to a cyclin box important for the interaction with cdc2-related kinase. These results suggest 
that the 23 kDa subunit, but not cyclin, activates cdk5 in neuronal cells, which no longer exhibit cell cycling but are terminally differentiated cells. 
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1. Introduction 
Paired helical filaments (PHF), /? amyloid and neu- 
ronal death are characteristics of the brains of Alz- 
heimer’s disease patients. PHF contain abnormally 
phosphorylated tau protein. The phosphorylation re- 
flects the physiolo~~l state in the brain of an Alz- 
heimer’s disease patient. An enzyme catalyzing this phos- 
phorylation was found to be tau protein kinase (TPK, 
EC 2.7.1.135) in microtubule proteins of bovine brain [ 11. 
Later, from the kinase fraction, we purified two protein 
kinases, TPKI and TPKII [2]. TPKI phospho~lated na- 
tive tau in a PHF-like manner, indicating that TPKI is 
a strong candidate for an enzyme catalyzing the abnor- 
mal phosphorylation. TPKI is identical to glycogen syn- 
thase kinase (GSK) 38 [3]. TPKYGSK38 was found to 
be involved in p amyloid-mediated neuronal death [4]. 
These results suggest hat TPKIIGSK3p might be a key 
enzyme in the disease. 
Native tau was already phosphorylated to some ex- 
tent, and this normal phosphorylation enhanced the 
abnormal phosphorylation by TPKIfGSK3/?, because 
TPKI/GSK3/? recognized the normally phospho~lated 
sites on tau [5]. As a candidate for a kinase involved in 
the normal phosphorylation, we found TPKII. TPKII 
phosphorylates four SerPro or ThrPro sites in tau [6]. 
Prior phosphorylation of tau by TPKII enhanced phos- 
phorylation by TPKI, indicating that TPKII may regu- 
*Corresponding author. Fax: (8 1) (427) 24 63 17. 
late the phosphorylation state of tau in Alzheimer’s dis- 
ease brain indirectly. Phospho~lation sites by TPKI [7] 
and TPKII [6] were close to each other and found to be 
phosphorylated in human PHF-tau [S] and rat juvenile- 
tau [9], suggesting that the TPKUTPKII-phosphoryla- 
tion system works both in Alzheimer’s disease and juve- 
nile brain. Two common features of these brains are 
sprouting [lo] and neuronal death. It is likely that these 
TPKs are involved in one or both of these phenomena. 
TPKII is known to have a cdc2-like kinase activity. 
This is supported by its high substrate specificity for 
histone Hl [2], its recognition of the Ser/ThrPro se- 
quence 16, I I] and its kinase activity towards the neurofil- 
ament-H subunit (NF-H) [ 12,131 in a manner similar to 
cdc2 kinase [14]. 
TPKII is composed of a 30 kDa catalytic subunit and 
a 23 kDa subunit [2]. The 30 kDa subunit is a cdc2- 
related kinase known as PSSALREfcdkS [ 151. The in- 
volvement of PSSALRE/cdkS in the abnormal phospho- 
rylation on PHF-tau in brain has been recently 
supported also by other groups [l&17]. This kinase was 
o~ginally found as a cdcZrelated kinase having a 
PSSALRE sequence instead of a PSTAIRE sequence 
shared by the well-known cdc2-related kinase [18]. Later, 
the PSSALRE kinase was reported to be associated with 
D type cyclin in human fibroblasts and has been called 
cyclin-dependent kinase 5 (cdk5) [ 191. Recently, 
PSSALRElcdkS was also cloned from a rat brain cDNA 
library as a neuronal cdc2-like kinase (nclk) [20]. Lew et 
al. purified a proline-directed protein kinase homologue 
from bovine brain, using a good substrate peptide (pro- 
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Src) for detecting cdcZrelated kinase activity [21]. The 
kinase (brain proline-directed protein kinase, BPDK) 
was also composed of cdk5 and another subunit (25 
kDa) [22]. Although the estimation of the molecular 
weight was different, the accessory protein seems to be 
identical to the 23 kDa subunit. The cDNA cloning and 
the enzyme purification from brain indicate that cdk5 is 
the most prominent cdcZrelated protein kinase in the 
brain. 
CdQ-related kinases (cyclin-dependent kinases) are 
active only in complexes with their regulatory subunits 
known as cyclins [23]. It seems reasonable that the 23 
kDa subunit may act as a regulatory factor for TPKII 
phosphorylation. In order to understand the role of the 
23 kDa subunit, it is important to determine the amino 
acid sequence and function of the 23 kDa subunit. 
Here, we show its sequence and suggest a role for this 
subunit. 
2. Materials and methods 
2.1. Materials 
Bovine TPKII was purified by the method described previously [2]. 
The anti-30 kDa subunit antibody was also described previously as an 
antibody against peptide 2 [15]. Anti-cyclin Dl antibody was purchased 
from UBI. 
2.2. Sequencing 
The TPKII-23 kDa subunit was separated from the 30 kDa subunit 
by reverse-phase column (C4, Aquapore BU-300,2.1 x 30 mm, Applied 
Biosystems) chromatography with a linear gradient (0.9 ml) of &70% 
acetonitrile in 0.1% trilluoroacetic acid, and digested by Acromobacter 
lyticus protease I (API) (Wake Pure Chemical Industries) and protease 
V8 (Boehringer Mannheim) in a reaction mixture of 4 M urea, 20 mM 
methylamine, 1 mM ethylenediaminetetraacetic acid and 40 mM so- 
dium phosphate buffer (pH 8.5) at a protein/weight ratio of 1O:l at 
37°C for 18 h. Several peptides were purified from the digest by reverse- 
phase column (C8, Aquapore RP-300, 2.1 x 30 mm, Applied Biosys- 
terns) chromatography under the same condition as mentioned above. 
The amino acid sequences were determined by a pulse-liquid-phase 
amino acid sequencer (Applied Biosystems 477A protein sequencer). 
Probes 1 and 2 were guessmers chemically synthesized based on the 
amino acid sequences of the corresponding peptide fragments 1 and 3 
of the 23 kDa subunit, respectively. Sequences of probe 1 and 2 were 
5’-ATGCTIC/GlCAGAT[C~AAIC/TlGA[C/T]CC[C~/A]CACTAC- 
TTCAC-3’- and 5’-GCjC~CAGCd[Cfi]CC[C~CC[C~/T/A]GC[C/ 
TlCAGCC-3’. resnectivelv. cDNA of the bovineTPKII-23 kDa subunit 
1 , I 
was cloned from a bovine brain cortex cDNA library (Clontech) using 
probes 1 and 2. 
The cDNA was ligated to the universal inker that was cut at the 
EcoRI sites and inserted into the vector, pUC19. DNA was sequenced 
cycle 1 2 3 4 5 6 7 8 9 10 11 12 
by dideoxy-mediated sequencing [24]. PCR was done by a GeneAmp 
DNA amplification reagent kit (Perkin-Elmer Cetus) using a cDNA 
clone as a template and two primers. Sequences of the sense primer 
(primer 1) and antisence (primer 2) were 5’-GCAGCTATCAGAAC- 
AACATCACGCACC-3’ and S-TTCCTGCGGAGCTGACGGCAG- 
GGTGC-3’, respectively. 
2.3. Other methods 
Peptides were synthesized by the solid phase method, using a Bio- 
search model 9500 peptide synthesizer. The sequence of the synthetic 
peptide substrate @ro-Src) &as RRPDAHRTPNRAF. An antibody 
against the peptide (KAQPPPAQPPAPPASQLSGSQTGV) was pre- 
pared by the method described previously [15]. Immunoblotting was 
performed with an ABC kit (Vector Laboratories). 
3. Results 
The 23 kDa subunit was separated from cdk5 using 
reverse-phase column chromatography. A digest of the 
23 kDa subunit was made using lysylendopeptidase 
(API) and V8 protease. Three peptides obtained from the 
digest were sequenced (Fig. 1). The N-terminal amino 
acid sequence of the 23 kDa protein is identical to that 
of fragment 1. A search for homologous proteins based 
on the sequences of these peptides revealed that these 
sequences are novel. We prepared an antibody against 
the peptide corresponding to amino acid residue number 
1 to 23 of fragment 1. This antibody was confirmed to 
react with the 23 kDa subunit. 
Cdk5 was also found to be a catalytic subunit of 
BPDK [22], cdc2-related kinase purified from bovine 
brain by Lew et a1.[21]. BPDK was reported to contain 
a 25 kDa subunit. In order to compare the 25 kDa sub- 
unit with the TPKII-23 kDa subunit, the anti-23 kDa 
subunit antibody was used as a probe monitoring the 
presence of the 23 kDa subunit during the purification 
of cdk5 from new-born bovine brain by their method 
[21]. We found that the kinase activity phosphorylating 
cdc2 kinase-specific substrate (pro-Src peptide) was 
eluted at an apparent molecular weight of 50,000, to- 
gether with the 23 kDa subunit immunoreactivity at gel 
filtration step (Fig. 2), indicating that the active kinase 
contains the 23 kDa subunit. On the other hand, most 
of the cdk5 immunoreactivity was eluted at a molecular 
weight of 30 kDa, indicating that most of cdk5 exists as 
an inactive monomer. The result suggest hat TPKII is 
13 14 1.5 16 17 18 19 20 21 22 23 24 25 26 
fr. 1 A Q P P (P) A Q P P A P P A S Q L S G S Q (T) G V (S) (S) (S) 
fr. 2 K A P(H) P A V S (S) A G T 
(P) 
fr. 3 M L Q I N A D P (H)(Y)(F)(T) 
Fig. 1. Amino acid sequence of three peptide fragments (fragment 1,2 and 3) obtained from a digest of the TPKII-23 kDa subunit. Residues of which 
the identities are uncertain from protein sequence analysis are in parentheses. 
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A. Activity 
50 kd 30 kd 
( pmole / min ) * a ‘b 
fr. no. 35 36 37 38 39 40 41 42 43 44 
C. lmmunoblot 
a b 
TPKII 
30 kd - 
23 kd - 
Fig. 2. Gel titration of cdc2-related kinase activity. (A) The kinase 
activity. The activity phosphorylating pro-Src peptide was eluted at 
apparent molecular weight of 50 kDa. (B) 5 ~1 and 20~1 of the fractions 
were immunoblotted with anti-30 kDa subunit (cdk5) and anti-23 kDa 
subunit antibodies, respectively. (C) Fractions a and b in panel A were 
collected and double-immunoblotted with anti-30 kDa subunit and 
anti-23 kDa subunit. 
identical to BPDK. In addition, the active fraction did 
not react with anti-cyclin Dl antibody by immunoblot 
analysis (data not shown), though cyclin Dl was re- 
ported to associate with cdk5 in fibroblast [19]. In neural 
cells, the 23 kDa subunit may be an activator for cdk5 
in a manner similar to cyclin for cdc2-related kinase. 
Using guessmers corresponding to fragment 1 and 3 
as hybridization probes (probe 2 and 1, respectively), 3 
cDNA clones were obtained from 4 x lo5 clones of a 
bovine brain cortex cDNA library. Sequencing of two of 
these cDNAs revealed that the cDNA had sequences 
corresponding to all three peptide fragments that we 
obtained (Fig. 3). A termination codon was found at 
position 628 (Fig. 3B). From the Ala at position 1 to the 
TGA termination codon at 628, there are 209 amino acid 
residues coding for a protein of 23,000 Da. We have 
determined the sequence of 183 nucleotides upstream of 
the Ala codon at position 1, and found neither an initia- 
tion codon nor a termination codon in the open reading 
frame indicated in Fig. 3A. Cleavage of the precursor of 
the 23 kDa protein is between a phenylalanine and the 
alanine at position 1. 
Cyclins share a common sequence which is thought to 
be involved in interaction with cdcZrelated kinase 
[25,26]. The region is called a cyclin box. Cdk5 was re- 
ported to bind to cyclin Dl in fibroblasts [19]. It is inter- 
esting that the 23 kDa subunit contains a region of weak 
homology with the cyclin box of cyclin Dl (Fig. 4). This 
region may associate with cdk5. 
The 23 kDa subunit has no homologous sequence to 
human pl3’““, another protein binding to cdc2 kinase 
[27], indicating that the interaction of the 23 kDa subunit 
with cdk5 is not similar to that of ~13”“’ with cdc2 
kinase. 
The C-terminal half of the 23 kDa subunit is homolo- 
gous to the human expression sequence tag (EST02338) 
(Fig. 3), recently reported from work involved with the 
human genome project [28-301. No protein encoded by 
the gene containing EST02338 has previously been re- 
ported. However, we now have identified EST02338 as 
a partial sequence ncoding the human 23 kDa subunit 
of TPKII. We observed only 17 differences in a stretch 
of 281 nucleotide residues (94% identity). The differences 
do not change amino acid residues, indicating that the 
protein is highly conserved between bovine and human. 
4. Discussion 
It is concluded from the experiments reported here 
that TPKII is comprised of two subunits; cdk5, a cata- 
lytic subunit, and a 23 kDa regulatory subunit. Determi- 
nation of the location of cdk5 upon gel filtration showed 
that cdk5 can be found in two different size fractions; a 
30 kDa monomer which had no kinase activity and a 50 
kDa complex (cdk5 and the 23 kDa subunit) which was 
able to phosphorylate the pro-Src substrate, indicating 
that the 23 kDa subunit is an activator of PSSALREI 
cdk5 in brain cells. This observation is supported by the 
work of others [17]. It has been well established that 
cdcZrelated kinases use members of the cyclin family as 
activators. Cdd-related kinases bind to different mem- 
bers of the cyclin family in different parts of the cell cycle 
[23] and this interchange of cdcZrelated kinases with the 
different cyclins is thought to regulate the progression of 
the cell through the cell cycle. The lack of similarity 
between the 23 kDa subunit of TPKII and cyclins, taken 
together with the fact that neurons are terminally differ- 
entiated cells not progressing through a cell cycle, sug- 
gests that the 23 kDa protein is not a cyclin. Association 
of cdk5 with cyclin Dl in fibroblasts [19] and with the 
23 kDa protein in neurons may reflect the need to recog- 
nize different substrates in these two distinctly different 
cell types. 
There is weak homology between the 23 kDa protein 
and cyclins within the cyclin box. The cyclin box [25] has 
been shown to be sufficient o account for the binding of 
cdc2-related kinases and cyclins [26]. Interestingly, the 
cyclin box with most similarity to the 23 kDa protein is 
that of cyclin Dl [31] which also binds to cdk5 [19]. It 
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Pl P2 
A 100 bp 
B 
Probe 2 
1 
31 
61 
91 
121 
151 
161 
GCCCAGCCCCCGCCGGCCCAGCCGCCCGCCCCCCCTGCCAGCCAGGICTCGGG~TCGCAGACCGGGGTCTCCTCG~CCG~CAAGAAGGCC 
AOPPPAOPPAPPASOLSGSOTGVSSSVK~ 
Fragment 1 
CCGCACCCTGCCGTCAGCTCCGCAGGAACGCCCAAACGGGTCA~CG~CCAGGCGTCCACCAGCGAGC~GCTGCGCTGCC~GGGCGAG~~C 
PHPAVSSAGTPKRVIVOASTSELLRCLGEF 
Fragment 2 
CTCTGTCGCCGGTGClACCGCCTGAAGCACCTGTCCCCCACGGACCC~G~GC~ClGCGlGCGCAGCG~GGACCGClCGClGClGClGCAG 
LCAACYRLKHLSPTDPVLCVRSVDllSLLLO 
90 
I60 
210 
A 1 C G (EST) 
GGCTGGCAGGACCAGGGCTTCAlCACGCCGGCCAACGTGG~Cl~CClCTACAlGClClGCCGGGAlGlCAlClCClCCGAGGlGGGlTCC 
GNODOGFIlPANVVFLYMLCADVlSSEYGS 
NT C A N A 
GACCACGAGCTCCAGGCGGTCCTGClGACCTGCCTGTAGCCCllC 
DHELOAVLLTCLYLSVSVMGNEISVPLKPF 
Probe 1 
N NTC T A AT 
CTGGTGGAGAGCTGCAAGGAGGCCTTTTGGGACCGCTGC 
LVESCKEAFWDACLSVINLMSSKMLOINAD 
Fragment 3 
A A C +-- 
CCCCACTACTTCACGCAGGTGTTCTCCGACClGAAGAACGAGAGCGGCCAGGAGGACAAGAAGCGGClCC~CC~CGGGClGGACCGGlGA 
PHVFTDVFSDLKNESGOEDKKALLLGLDRt 
209 
360 
(EST) 
450 
(EST) 
540 
(EST) 
630 
GCCCGCCAGCCTGCATCATGGCTCAAGGATTCAATTCATTTTTAAA 
676 
Fig. 3. Structure of cDNA No. 5 of bovine TPKII-23 kDa subunit. (A) Restriction map of the cDNA No.5 of bovine TPKIL23kDa. Its length is 
about 1020 bp. Arrows indicate the region and direction of DNA strand that the sequencing analysis has been done. Two small arrows, pl and p2, 
indicate the hybridizing positions of primers for PCR. The PCR product has also been sequenced to confirm the sequence. Abbreviations of restriction 
points are as follows: E, EcoRI; P, PstI; D, DraI; H, HaeIII. The box indicates an extensive open reading frame; the hatched portion of the box 
corresponds to the 23 kDa subunit. (B) Sequence of the bovine TPKII-23 kDa subunit. The nucleotide sequence starts at the site corresponding to 
the N-terminal of the 23 kDa subunit and ends at the DraI site. The full length of the amino acid sequence of the subunit is shown. Fragment 1, 
2 and 3 indicate sequences of peptides obtained from API and V8 digests. Oligonucleotide probes 1 and 2 were used for cDNA cloning. A nucleotide 
sequence of human tag EST02338 is indicated by the sequence between two arrows below that of the 23 kDa subunit. Only differences in the sequences 
are indicated by characters in the lines marked EST. 
may be that binding of the 23 kDa protein to cdk5 is 
through these residues that exhibit homology to cyclin 
Dl. 
The 23 kDa subunit was derived from a large precur- 
sor by cleavage between a phenylalanine and alanine 
residue, suggesting that a chymotrypsin-like protease is 
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ZBKD 
CYCDl 
CYCDZ 
CYCD3 
CYCA 
CYCB 
CYCC 
CYCE 
23KD 
CYCDl 
CYCDZ 
CYCD3 
CYCA 
CYCB 
CYCC 
CYCE 
aa 
73 PTDPVLCVRSVDRSLLLPGWQD-QGFIT--PANVVFLYMLCRDVlSSEVGSDHELQAVLLT 
.I[ I. . I. . .I . .I II * 
1 MEHQLLCCE-VETIRRAYP--DANLLND--RVLRAMLK-AEETCAPSVSYFKCVQKEVLPS 
1 ME--LLCHE-VDPVRRAVR--DRNLLRDD-RVLQNLLT-IEERYLPQCSYFKCVQKDlQPY 
1 ME--LLCCECTRHAPRACP--DPRLLGDQ-RVLQSLLR-LEERYVPRASYFQCVQRElKPH 
150 GSFESPHTMDMSIVLEDEKPVSVNEVPDYHEDIHTYLREMEVKCKPKVGYMKKQP-DITNS 
143 LCQAFSDVlLAVNDVDAEDCADPNLCSEYVKDlYAYLRQLEEEQAVRPKYLLGR--EVTGN 
1 MVAPRPLRRVVLFYQGKLCSMAGNFWQSSHYLQWILDKQDLLKERQKDLKFL-SEEEYWK 
70 RVYPNSTCKPRIIAPSRCSPLPVLSWANREEVWKIMLN-KEKTYLRDQHFLE-QHPLLQPK 
* * 
w 
aa 
131 CLYLSYSYMGNEISYPLKPFLVESCKEAFWDRCLSVINLMSSKMLQINADPHYFTQVFSDLK 
. . . I *IIll* * I*II- I 
56 MRKIVATWMLEVCEEQKCEEEVFPLAMNYLDRFLSLEPVKKSR-LQLLGATCMFVASKMKET 
55 MRRMVATWMLEVCEEQKCEEEVFPLAMNYLDRFLAGVPTPKSH-LQLLGAVCMFLASKLKET 
56 MRKMLAYWMLEVCEEQRCEEEVFPLAMNYLDRYLSCVPTRKAQ-LQLLGAVCMLLASKLRET 
209 MRAILVDWLVEVGEEYKLQNETLHLAVNYIDRFLSSMSVLRGK-LQLVGTAAMLLASKFEEI 
201 MRAILlDWLVQVQMKFRLLQETMYMTVSllDRFMQNNCVPK-KMLQLVGVTAMFlASKYEEM 
60 LQIFFTNVIQALGEHLKLRQQVIATATVYFKRFYARYSL-KSIDPVLMAPTCVFLASKVEEF 
129 MRAILLDWLMEVCEVYKLHRETFYLAQDFFDRYMATQENVVKTLLQLlGlSSLFlAAKLEEl 
. . . . . . ., et* ..* . *** * 
aa 
23KD 193 NESCQEDKKRL-LLCLD-R 209
I I I 
CYCDl 117 IPLTAEKLCIY-TDGSI-R------PEELLQMELLLVNKLKWNLAAMTPHDFIEHFLS 
CYCDZ 116 SPLTAEKLCIY-TDNSI-K------PQELLEWELVVLGKLKWNLAAVTPHDFlEHlLR 
CYCDS 117 TPLTIEKLCIY-TDHAV-S------PRQLRDWEVLVLGKLKWDLAAVlAHDFLAFILH 
CYCA 271 YPPEVAEFVYI-TDDTYTK-------KQVLRMEHLVLKVLTFDLAAPTVNQFLT-QYF 
CYCB 262 YPPEICDFAFV-TDNTYTK-------HQlRQMEMKlLRALNFGLGRPLPLHFLR-RAS 
CYCC 121 GVVSNTRLlAAATSVLKTRFSYAFPKEFPYRMNHILEC--EFYLLELMDCCLlVYHPY 
CYCE 191 YPPKLHQFAYV-TDCACSC-------DElLTMELMIMKALKWRLSPLTiVSWLNVYMQ 
*. * t 
H Y 
Fig. 4. Homology between the 23 kDa subunit and cyclins. A partial amino acid sequence of23 kDa subunit (23KD) is compared with those of the 
cyclin box region of human cyclin A (CYCA) [32], B (CYCB) [33], C (CYCC) [34], Dl (CYCDI) [34], D2 (CYCD2) [35], D3 (CYCD3) [35] and E 
(CYCE) [34]. Asterisks and dots under the sequences are completely and almost conserved amino acid residues among these cyclins, respectively. 
Arrows indicate binding regions of cyclin A to cdc2 kinase [26]. Vertical lines and dots between the 23 kDa subunit and cyclin Dl indicate the identical 
and homologous amino acid residues between the two proteins, respectively, both of which can bind to cdk5. 
responsible for the generation of the 23 kDa protein. We 
know from sequence analysis of our current clones that 
the precursor must be at least 30 kDa. We are presently 
in the process of determining the exact size of the precur- 
sor. 
Comparison of the amino acid sequence with proteins 
in the data base did not show any protein closely related 
to the 23 kDa subunit. However, when compared to the 
expression sequence tag (EST) sequences, we found that 
EST02338 from a human cDNA library contains a par- 
tial coding region for a protein that is 94% identical in 
sequence to the 23 kDa subunit. ESTs are regarded as 
a powerful physical mapping strategy in the human 
genome project [28]. Automated partial DNA sequenc- 
ing was conducted on many randomly selected human 
brain cDNA clones to generate ESTs [29]. A proportion 
of ESTs encode unknown proteins [30]. Now, one of the 
ESTs has been identified as the partial sequence encod- 
ing a homolog of an important component of TPKII, a 
kinase that is associated with the developmental stage of 
the neuron and with Alzheimer’s disease. 
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